Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Whole Genome Sequencing
40%
COVID-19
37%
Infection
34%
Surveillance
30%
Patient
28%
Virus
23%
Resident
21%
Circulation
17%
Therapeutic Procedure
16%
Analysis
14%
Person
14%
Symptom
14%
Vaccine
14%
Hospital
13%
Nursing Home
12%
Pathology
12%
Molecular Epidemiology
12%
Tissues
11%
Host
10%
Polymerase Chain Reaction
10%
Health
9%
Usutu Virus
9%
Genome Sequencing
9%
Amplicon
8%
Haplotype
8%
Coronavirinae
8%
Pathogenesis
8%
Plasma
8%
In Vitro
8%
Next Generation Sequencing
8%
Diagnosis
8%
Household
7%
Immunocompromised Patient
7%
Introspection
7%
Clotiazepam
7%
Immunity
6%
Public Health
6%
Lesion
6%
Emergency
6%
Norovirus Infection
6%
Immunoglobulin
6%
Common Variable Immunodeficiency
6%
Tertiary Care
6%
Environmental Exposure
6%
Ritonavir
6%
Occupational Exposure
6%
Death
6%
T-Cell Response
6%
Convalescence
6%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
90%
Sample
36%
Whole Genome Sequencing
33%
Neovison Vison
32%
Mutation
28%
Virus
28%
Circulation
22%
Vaccine Efficacy
18%
Human
17%
Animal
16%
COVID-19
16%
Lineages
16%
Health
15%
Time
15%
Dynamics
12%
Metagenomics
9%
Introspection
9%
Adaptation
9%
Host
9%
Epidemiological Data
8%
Immunity
8%
Amplicon
8%
Electric Potential
7%
One Health
7%
Immunocompromised Patient
6%
Sex
6%
Gorilla
6%
Lion
6%
Molecular Epidemiology
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Bioinformatics
6%
Screening
6%
Tissues
6%
Central Nervous System
6%
Rabies Virus
6%
Mouse
6%
Polymerase Chain Reaction
6%
Phylogeny
6%
Virus Transmission
5%
Monospecific Antibody
5%
Decision Making
5%
Genome Sequencing
5%
